ClinicalTrials.Veeva

Menu

The Study of Ropivacaine Median Effective Concentration in Ultrasound-guided Supraclavicular Brachial Plexus Block

Y

Yu Shan

Status and phase

Unknown
Phase 4

Conditions

Anesthesia

Treatments

Drug: ropivacaine

Study type

Interventional

Funder types

Other

Identifiers

NCT02323282
Yu Shan

Details and patient eligibility

About

To determine the median effective concentration of ropivacaine hydrochloride for ultrasound-guided supraclavicular brachial plexus block. The result can provide reference for choosing appropriate drug concentration in clinical anesthesia.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 64 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • ASA I or II

Exclusion criteria

  • upper limb paresthesia
  • allergic to local anesthetics
  • surgery history of clavicle
  • BMI>30kg/m^2

Trial design

60 participants in 1 patient group

ropivacine
Other group
Treatment:
Drug: ropivacaine

Trial contacts and locations

1

Loading...

Central trial contact

Shan Yu

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems